 Abiraterone is sold under brand name

Abirapro 500mg
 Abirapro 500mg tablet is exist to type of
anti-cancer drug that will execution by
slump the androgen production in the
body. Androgen is a male hormone that
can provide the tumor cell in prostate
glands. This drug is given by co organization
with prednisolone, a steroid which
decrease the burden of side effects
produced by Abirapro.
 Androgens are harmony the production
of diseased in prostate.
 Abirapro 500mg exist to anti androgen
drugs, that purpose to contain the
enzyme 17α-hydroxylase C 17, 20-lyase
(CYP17), it is including in androgen
conglomerate.
 Decrease the serum testosterone level.
 Refuse the tumor cell occurred.
 Absorption: Time to maximum plasma combination
of Abirapro 500mg takes 12 hours.
 Distribution: Maximum bound to the human plasma
protein like albumin and alpha-1 acid glycoprotein.
 Metabolism: The main two metabolites of Abirapro
500mg tablet in human plasma are Abiraterone
sulphate and N-oxide Abiraterone sulphate.
 Excretion: The drug mainly excreted in 88% feces and
5% in urine
 Half-life of tablet Abirapro 500mg is 12 ± 5 hours.
 Common effects
 Fatigue, Arthralgia, Hypertension, Nausea,
edema, Hypokalemia, Diarrhea, vomiting,
Cough, headache, Glucocorticoid
deficiency, Mineral corticoid deficiency,
Hepatotoxicity, Hypertension, Decrease in
ka level, Adrenocortical insufficiency
 Muscular skeletal and Connective tissue
disorders: Joint swelling, discomfort, muscle
discomfort
 General Disorder: Edema
 The prescribed dose of Abirapro 500mg is initial
as 4 tablets given orally once daily.
 The drug Abirapro 500mg execute sequence
with 5mg prednisolone twice daily in vacant
stomach.
 Abirapro 500mg tablet given on avacant
stomach.
 Food should not be taken for at least 2 hours
before and at least 1 hour after the dose of
Abirapro 500mg is taken.
 Consume whole with water.
 Chomp the tablets or Do not crush
 Cooperation Abirapro 500mg with strong
CYP3A inhibitors or inducers, concomitant
use with prudence because
pharmacokinetics is not estimated.
 cooperation of Abirapro 500mg tablet with
dextromethorphan will accession the
Cmax and AUC of dextromethorphan
 SAFETY AND WARNING OF Abirapro 500mg
Any allergy, severe liver problem or
pregnant in patient, Abirapro 500mg tablet
therapy should be interrupted
 OVERDOSAGE
 Abirapro 500mg has no vital antidote, if
overdose develop end treatment with the
drug and give general supportive measures
such as monitoring arrhythmias and cardiac
failure and assess liver function.
 MISSED DOSE
 If patient missed the dose of Abirapro
500mg tablet , that missed dose will be
skipped and follow the regular dosing
schedule.
 PREGNANCY
 Pregnancy category X: while on therapy
with Abirapro 500mg if women become
pregnant, immediately stop the drug and
give counseling to the women. Abirapro
500mg tablet is not recommended for
women.
 LACTATION
 Abirapro 500mg not used in women
excretion in human milk is unknown and the
drug effects in the nursing infant is
unknown.
 PHONE NO: +919940472902

 E-MAIL:
millionhealthpharmaceuticals@gmail.com

 WEBSITE
URL:https://pillsbag.com/products/abirapro-
500mg

 KEYWORDS: Abirapro 500mg , Abirapro 500mg

tablet , Abirapro 500mg price in india